期刊文献+

腹泻型肠易激综合征患者结肠黏膜5-羟色胺和5-羟色胺_3受体的研究 被引量:21

Changes of Colonic 5-Hydroxytryptamine and 5-Hydroxytryptamine_3 Receptors in Diarrhea-predominant Irritable Bowel Syndrome
在线阅读 下载PDF
导出
摘要 背景:肠易激综合征(IBS)是一种功能性胃肠道疾病,其病因和发病机制迄今尚未完全阐明。目的:探讨5-羟色胺(5-HT)和5-HT3受体(5-HT3R)在腹泻型IBS(D-IBS)患者结肠黏膜中的变化及其临床意义。方法:对18名正常人和28例D-IBS患者行结肠镜检查并分别取升结肠、横结肠、降结肠和乙状结肠黏膜标本各两块。以免疫组化方法检测5-HT阳性细胞;以蛋白质印迹分析半定量检测5-HT3R的表达。结果:D-IBS组4个部位结肠黏膜的5-HT阳性细胞数和5-HT3R的表达均较正常对照组显著增多(P<0.05),但4个部位之间相互比较均无显著差异。结论:D-IBS患者结肠黏膜5-HT合成和分泌增多,5-HT3R表达上调,提示5-HT和5-HT3R可能为D-IBS的分子生物学基础之一,为D-IBS的治疗提供了分子靶点。 Background: Irritable bowel syndrome (IBS) is a functional gastrointestinal tract disease. Its cause and mechanism remain unclear. Aims: To appraise the changes and clinical significances of 5-hydroxytryptamine (5-HT) and 5-HT3 receptor (5-HT3R) in colonic mucosa of diarrhea-predominant IBS (D-IBS) patients. Methods: The distribution of 5-HT positive cells was measured by immunohistochemistry and expression of 5-HT3R by Western blot in four biopsied sections from the ascending, transverse, descending and sigmoid colon of 18 healthy controls and 28 D-IBS patients. Results: The number of 5-HT positive cells and the expression of 5-HT3R in all sections of colonic mucosa in D-IBS patients increased markedly compared to those in healthy controls (P〈0.05). No significant differences in expression of 5-HT3R were found among the four colonic sections as well as the number of 5-HT positive cells. Conclusions: The synthesis and excretion of 5-HT and expression of 5-HT3R were increased significantly in D-IBS patients, suggesting that 5-HT and 5-HT3R are involved in the pathogenesis of D-IBS, which may offer a molecular target for treatment.
出处 《胃肠病学》 2006年第8期477-480,共4页 Chinese Journal of Gastroenterology
基金 苏威全国肠易激综合征研究基金资助
关键词 腹泻 肠易激综合征 血清素 受体 血清素 Diarrhea Irritable Bowel Syndrome Serotonin Receptors, Serotonin
  • 相关文献

参考文献9

  • 1Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol, 2004, 141:1285-1293.
  • 2Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ,Rimmer MJ. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut, 2003, 52:663-670.
  • 3杨云生.肠易激综合征的发病机制[J].医师进修杂志,2003,26(8):7-9. 被引量:14
  • 4詹丽杏,许国铭,李兆申,邹多武,金震东,屠振兴.肠易激综合征患者活动期和缓解期血浆5-HT、5-HIAA的变化[J].第二军医大学学报,2003,24(2):152-154. 被引量:33
  • 5李兆申,詹丽杏,邹多武,许国铭,满晓华,叶熙亭.肠易激综合征患者分泌5-羟色胺的肠嗜铬细胞形态及功能的改变[J].中华消化杂志,2004,24(2):94-97. 被引量:68
  • 6Kozlowski CM, Green A, Grundy D, Boissonade FM,Bountra C.The 5-HT (3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut, 2000, 46: 474-480.
  • 7Nishiyama H, Mizuta Y, Isomoto H, Takeshima F,Omagari K, Miyahara Y, Murata I, Kohno S. Chronic visceral hypersensitivity renders defecation more susceptible to stress via a serotonergic pathway in rats.Dig Dis Sci, 2004, 49: 763-769.
  • 8Houghton LA, Foster JM, Whorwell PJ. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.Aliment Pharmacol Ther, 2000, 14: 775-782.
  • 9Liu MT, Rayport S, Jiang Y, Murphy DL, Gershon MD.Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter.Am J Physiol Gastrointest Liver Physiol, 2002, 283:G1398-G1411.

二级参考文献19

  • 1唐爱国,吴轰,高洁生,杨锡兰.高效液相色谱-电化学检测法同时测定血浆中5-羟色胺和5-羟吲哚乙酸[J].色谱,1995,13(6):472-475. 被引量:14
  • 2Heateon KW, O' Donnell LD, Braddon FE, et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology, 1992,102: 1962-1967.
  • 3Ferguson A, Sircus W, Eastwood MA. Frequency of functional gastrointestinal disorders. Lancet, 1977,2:613-614.
  • 4Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet, 1983,1: 632-634.
  • 5Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhea predominant irritable bowel syndrome:a pilot study. Gut, 1998,42:42-46.
  • 6Thompson WG. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Corazziari E, Jalley NJ, eds. Functional gastrointestinal disorders: Rome Ⅱ . Mclean Virginia: Dgnon and Associates,2000. 360-382.
  • 7Miura M, Lawson DC, Clary EM, et al. Central modulation of rectal distension induced blood pressure changes by alosetron , a 5 HT3 receptor antagonist. Dig Dis Sci, 1999,44: 20-24.
  • 8Kozlowski CM, Green AN, Grundy D, et al. The 5-HT3 receptor antagonist alosetron inhibits the colorectal distention induced de pressor response and spinal c-fos expression in the anaesthetised rat. Gut, 2000,46: 474-480.
  • 9Kuemmerle JF, Murthy KS, Grider JR, et al. Coexpression of 5HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology, 1995, 109:1791-1800.
  • 10Tack J, Coulie B, Wilmer A, et al. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut, 2000, 46:468-473.

共引文献105

同被引文献229

引证文献21

二级引证文献243

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部